Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 857

1.

Patient-based prediction algorithm of relapse after allo-HSCT for acute Leukemia and its usefulness in the decision-making process using a machine learning approach.

Fuse K, Uemura S, Tamura S, Suwabe T, Katagiri T, Tanaka T, Ushiki T, Shibasaki Y, Sato N, Yano T, Kuroha T, Hashimoto S, Furukawa T, Narita M, Sone H, Masuko M.

Cancer Med. 2019 Jul 15. doi: 10.1002/cam4.2401. [Epub ahead of print]

PMID:
31305031
Free Article
2.

JunB plays a crucial role in development of regulatory T cells by promoting IL-2 signaling.

Katagiri T, Yamazaki S, Fukui Y, Aoki K, Yagita H, Nishina T, Mikami T, Katagiri S, Shiraishi A, Kimura S, Tateda K, Sumimoto H, Endo S, Kameda H, Nakano H.

Mucosal Immunol. 2019 Jul 8. doi: 10.1038/s41385-019-0182-0. [Epub ahead of print]

PMID:
31285535
3.

Microcrystalline array structures induced by heat treatment of friction-transferred organic semiconductor films.

Inada Y, Koda M, Urabe Y, Katagiri T, Yamao T, Yoshida Y, Hotta S.

Sci Rep. 2019 Jul 5;9(1):9739. doi: 10.1038/s41598-019-46212-w.

4.

Dual usage of a stage-specific fluorescent reporter system based on a helper-dependent adenoviral vector to visualize osteogenic differentiation.

Sone T, Shin M, Ouchi T, Sasanuma H, Miyamoto A, Ohte S, Tsukamoto S, Nakanishi M, Okano H, Katagiri T, Mitani K.

Sci Rep. 2019 Jul 4;9(1):9705. doi: 10.1038/s41598-019-46105-y.

5.

Single-isocenter volumetric-modulated Dynamic WaveArc therapy for two brain metastases.

Uto M, Ogura K, Mukumoto N, Miyabe Y, Nakamura M, Hirashima H, Katagiri T, Takehana K, Hiraoka M, Mizowaki T.

Jpn J Radiol. 2019 Jun 22. doi: 10.1007/s11604-019-00849-9. [Epub ahead of print]

PMID:
31230185
6.

Clonal hematopoiesis by SLIT1-mutated hematopoietic stem cells due to a breakdown of the autocrine loop involving Slit1 in acquired aplastic anemia.

Hosokawa K, Mizumaki H, Elbadry MI, Saito C, Espinoza JL, Thi Thanh Dao A, Katagiri T, Harashima A, Kikuchi A, Kanai A, Matsui H, Inaba T, Taniwaki M, Yamamoto Y, Nakao S.

Leukemia. 2019 Jun 11. doi: 10.1038/s41375-019-0510-0. [Epub ahead of print] No abstract available.

PMID:
31186493
7.

Inhibitory Effects of Phenylpropanoid Derivatives from Oenanthe javanica on Antigen-Stimulated Degranulation in RBL-2H3 Cells.

Murata T, Katagiri T, Ishikawa Y, Abe M, Takahashi E, Iwahana R, Sakamoto Y, Sasaki K.

J Nat Prod. 2019 Jun 28;82(6):1518-1526. doi: 10.1021/acs.jnatprod.8b01054. Epub 2019 May 24.

PMID:
31125231
8.

Development and exacerbation of pulmonary nontuberculous mycobacterial infection in patients with systemic autoimmune rheumatic diseases.

Takenaka S, Ogura T, Oshima H, Izumi K, Hirata A, Ito H, Mizushina K, Inoue Y, Katagiri T, Hayashi N, Kameda H.

Mod Rheumatol. 2019 Jun 4:1-6. doi: 10.1080/14397595.2019.1619220. [Epub ahead of print]

PMID:
31084231
9.

Quantification of Endolymphatic Space Volume after Intravenous Administration of a Single Dose of Gadolinium-based Contrast Agent: 3D-real Inversion Recovery versus HYDROPS-Mi2.

Ohashi T, Naganawa S, Takeuchi A, Katagiri T, Kuno K.

Magn Reson Med Sci. 2019 May 7. doi: 10.2463/mrms.mp.2019-0013. [Epub ahead of print]

10.

Rhnull phenotype caused by a novel RHAG mutation, c.945+1G>A, in the Japanese population.

Ushiki T, Tsuneyama H, Masuko M, Kozakai T, Kasami T, Tanaka T, Uchikawa M, Kitajima T, Kasai E, Komata T, Katagiri T, Kamimura M, Sato K, Fuse I, Ogasawara K, Nakata K.

Transfusion. 2019 Apr 16. doi: 10.1111/trf.15312. [Epub ahead of print]

PMID:
30990901
11.

Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer.

Iizuka Y, Katagiri T, Ogura K, Mizowaki T.

Ann Nucl Med. 2019 Jul;33(7):495-501. doi: 10.1007/s12149-019-01357-6. Epub 2019 Apr 6.

PMID:
30955202
12.

Escape hematopoiesis by HLA-B5401-lacking hematopoietic stem progenitor cells in men with acquired aplastic anemia.

Elbadry MI, Mizumaki H, Hosokawa K, Espinoza JL, Nakagawa N, Chonabayashi K, Yoshida Y, Katagiri T, Hosomichi K, Zaimoku Y, Imi T, Nguyen MAT, Fujii Y, Tajima A, Ogawa S, Takenaka K, Akashi K, Nakao S.

Haematologica. 2019 Mar 19. pii: haematol.2018.210856. doi: 10.3324/haematol.2018.210856. [Epub ahead of print]

13.

DNA demethylation with 5-aza-2'-deoxycytidine induces the senescence-associated secretory phenotype in the immortal fish cell line, EPC.

Futami K, Maita M, Katagiri T.

Gene. 2019 May 20;697:194-200. doi: 10.1016/j.gene.2019.02.048. Epub 2019 Feb 22.

PMID:
30802536
14.

Discovery of Heterotopic Bone-Inducing Activity in Hard Tissues and the TGF-β Superfamily.

Katagiri T, Tsukamoto S, Nakachi Y, Kuratani M.

Int J Mol Sci. 2018 Nov 13;19(11). pii: E3586. doi: 10.3390/ijms19113586. Review.

15.

Signal Intensity of the Cerebrospinal Fluid after Intravenous Administration of Gadolinium-based Contrast Agents: Strong Contrast Enhancement around the Vein of Labbe.

Ohashi T, Naganawa S, Ogawa E, Katagiri T, Kuno K.

Magn Reson Med Sci. 2019 Jul 16;18(3):194-199. doi: 10.2463/mrms.mp.2018-0043. Epub 2018 Nov 9.

16.

A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancer.

Kato Y, Zembutsu H, Takata R, Matsuura T, Kato R, Kanehira M, Iwasaki K, Yamada N, Katagiri T, Sugai T, Fujioka T, Nakamura Y, Obara W.

Oncol Lett. 2018 Nov;16(5):5775-5784. doi: 10.3892/ol.2018.9330. Epub 2018 Aug 20.

17.

Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.

Tamura S, Kawamoto K, Miyoshi H, Suzuki T, Katagiri T, Kasami T, Nemoto H, Miyakoshi S, Kobayashi H, Shibasaki Y, Masuko M, Takeuchi K, Ohshima K, Sone H, Takizawa J.

J Clin Exp Hematop. 2018 Dec 13;58(4):161-165. doi: 10.3960/jslrt.18015. Epub 2018 Oct 10.

18.

Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.

Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, Katagiri T, Yoshida T, Nakamura S, Sugano K, Miki Y, Hirata M, Matsuda K, Spurdle AB, Kubo M.

Nat Commun. 2018 Oct 4;9(1):4083. doi: 10.1038/s41467-018-06581-8.

19.

Recent Topics in Fibrodysplasia Ossificans Progressiva.

Katagiri T, Tsukamoto S, Nakachi Y, Kuratani M.

Endocrinol Metab (Seoul). 2018 Sep;33(3):331-338. doi: 10.3803/EnM.2018.33.3.331. Review.

20.

Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.

Fukuda T, Ishiyama T, Katagiri T, Ueda K, Muramatsu S, Hashimoto M, Aki A, Baba D, Watanabe K, Tanaka N.

Bioorg Med Chem Lett. 2018 Nov 1;28(20):3333-3337. doi: 10.1016/j.bmcl.2018.09.010. Epub 2018 Sep 8.

PMID:
30217414
21.

Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.

Deng B, Tarhan YE, Ueda K, Ren L, Katagiri T, Park JH, Nakamura Y.

Neoplasia. 2018 Oct;20(10):1038-1044. doi: 10.1016/j.neo.2018.08.006. Epub 2018 Sep 9.

22.

A potential novel option for cancer immunotherapy - TLR7 stimulation inhibits malignant melanoma bone invasion.

Katagiri T.

Oncotarget. 2018 Aug 7;9(61):31792. doi: 10.18632/oncotarget.25872. eCollection 2018 Aug 7. No abstract available.

23.

Dosimetric comparison between dual-isocentric dynamic conformal arc therapy and mono-isocentric volumetric-modulated arc therapy for two large brain metastases.

Uto M, Mizowaki T, Ogura K, Mukumoto N, Katagiri T, Takehana K, Hiraoka M.

J Radiat Res. 2018 Nov 1;59(6):774-781. doi: 10.1093/jrr/rry064.

24.

α-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10.

Li HK, Sugyo A, Tsuji AB, Morokoshi Y, Minegishi K, Nagatsu K, Kanda H, Harada Y, Nagayama S, Katagiri T, Nakamura Y, Higashi T, Hasegawa S.

Cancer Sci. 2018 Jul;109(7):2302-2309. doi: 10.1111/cas.13636. Epub 2018 Jun 27.

25.

A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.

Giraudet AL, Cassier PA, Iwao-Fukukawa C, Garin G, Badel JN, Kryza D, Chabaud S, Gilles-Afchain L, Clapisson G, Desuzinges C, Sarrut D, Halty A, Italiano A, Mori M, Tsunoda T, Katagiri T, Nakamura Y, Alberti L, Cropet C, Baconnier S, Berge-Montamat S, Pérol D, Blay JY.

BMC Cancer. 2018 Jun 8;18(1):646. doi: 10.1186/s12885-018-4544-x.

26.

Heterogeneity of intrahepatic iron deposition in transfusion-dependent iron overload patients with hematological malignancies.

Kobayashi H, Yoshimura N, Uemura S, Katagiri T, Tanaka T, Ushiki T, Fuse K, Shibasaki Y, Narita M, Sone H, Masuko M.

Leuk Res. 2018 Jul;70:41-44. doi: 10.1016/j.leukres.2018.05.005. Epub 2018 May 21. No abstract available.

PMID:
29803982
27.

Refinement of the Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.

Shibasaki Y, Suwabe T, Katagiri T, Tanaka T, Ushiki T, Fuse K, Sato N, Yano T, Kuroha T, Hashimoto S, Narita M, Furukawa T, Sone H, Masuko M.

Int J Hematol. 2018 Sep;108(3):282-289. doi: 10.1007/s12185-018-2463-x. Epub 2018 May 9.

PMID:
29744806
28.

BMPR2 inhibits activin and BMP signaling via wild-type ALK2.

Olsen OE, Sankar M, Elsaadi S, Hella H, Buene G, Darvekar SR, Misund K, Katagiri T, Knaus P, Holien T.

J Cell Sci. 2018 Jun 11;131(11). pii: jcs213512. doi: 10.1242/jcs.213512.

29.

Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.

Imi T, Katagiri T, Hosomichi K, Zaimoku Y, Hoang Nguyen V, Nakagawa N, Tajima A, Yoshizato T, Ogawa S, Nakao S.

Blood Adv. 2018 May 8;2(9):1000-1012. doi: 10.1182/bloodadvances.2017013953.

30.

Infrared Hollow Optical Fiber Probe for Localized Carbon Dioxide Measurement in Respiratory Tracts.

Katagiri T, Shibayama K, Iida T, Matsuura Y.

Sensors (Basel). 2018 Mar 27;18(4). pii: E995. doi: 10.3390/s18040995.

31.

Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders.

Machiya A, Tsukamoto S, Ohte S, Kuratani M, Fujimoto M, Kumagai K, Osawa K, Suda N, Bullock AN, Katagiri T.

Bone. 2018 Jun;111:101-108. doi: 10.1016/j.bone.2018.03.015. Epub 2018 Mar 15.

32.

HIF-1 maintains a functional relationship between pancreatic cancer cells and stromal fibroblasts by upregulating expression and secretion of Sonic hedgehog.

Katagiri T, Kobayashi M, Yoshimura M, Morinibu A, Itasaka S, Hiraoka M, Harada H.

Oncotarget. 2018 Jan 11;9(12):10525-10535. doi: 10.18632/oncotarget.24156. eCollection 2018 Feb 13.

33.

Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.

Miyagawa Y, Matsushita Y, Suzuki H, Komatsu M, Yoshimaru T, Kimura R, Yanai A, Honda J, Tangoku A, Sasa M, Miyoshi Y, Katagiri T.

Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4301. [Epub ahead of print]

PMID:
29512727
34.

Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack.

Espinoza JL, Elbadry MI, Chonabayashi K, Yoshida Y, Katagiri T, Harada K, Nakagawa N, Zaimoku Y, Imi T, Takamatsu H, Ozawa T, Maruyama H, Hassanein HA, Khalifa A Noreldin A, Takenaka K, Akashi K, Hamana H, Kishi H, Akatsuka Y, Nakao S.

Blood Adv. 2018 Feb 27;2(4):390-400. doi: 10.1182/bloodadvances.2017013342. Erratum in: Blood Adv. 2018 Sep 11;2(17):2253.

35.

A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer.

Daizumoto K, Yoshimaru T, Matsushita Y, Fukawa T, Uehara H, Ono M, Komatsu M, Kanayama HO, Katagiri T.

Cancer Res. 2018 May 1;78(9):2233-2247. doi: 10.1158/0008-5472.CAN-17-2528. Epub 2018 Feb 13.

36.

Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation.

Sato S, Nakamura T, Katagiri T, Tsuchikawa T, Kushibiki T, Hontani K, Takahashi M, Inoko K, Takano H, Abe H, Takeuchi S, Ono M, Kuwabara S, Umemoto K, Suzuki T, Sato O, Nakamura Y, Hirano S.

Oncotarget. 2017 Oct 19;8(69):113662-113672. doi: 10.18632/oncotarget.21939. eCollection 2017 Dec 26.

37.

Present status and future perspective of peptide-based vaccine therapy for urological cancer.

Obara W, Kanehira M, Katagiri T, Kato R, Kato Y, Takata R.

Cancer Sci. 2018 Mar;109(3):550-559. doi: 10.1111/cas.13506. Epub 2018 Feb 15. Review.

38.

The AP-1 transcription factor JunB is required for Th17 cell differentiation.

Yamazaki S, Tanaka Y, Araki H, Kohda A, Sanematsu F, Arasaki T, Duan X, Miura F, Katagiri T, Shindo R, Nakano H, Ito T, Fukui Y, Endo S, Sumimoto H.

Sci Rep. 2017 Dec 12;7(1):17402. doi: 10.1038/s41598-017-17597-3.

39.

Anthelmintic activity of Rosmarinus officinalis against Dactylogyrus minutus (Monogenea) infections in Cyprinus carpio.

Zoral MA, Futami K, Endo M, Maita M, Katagiri T.

Vet Parasitol. 2017 Nov 30;247:1-6. doi: 10.1016/j.vetpar.2017.09.013. Epub 2017 Sep 14.

PMID:
29080753
40.

Scopranones with Two Atypical Scooplike Moieties Produced by Streptomyces sp. BYK-11038.

Uchida R, Lee D, Suwa I, Ohtawa M, Watanabe N, Demachi A, Ohte S, Katagiri T, Nagamitsu T, Tomoda H.

Org Lett. 2017 Nov 3;19(21):5980-5983. doi: 10.1021/acs.orglett.7b03003.

PMID:
29063763
41.

Hyponatremia with Loss of High Signal Intensity in the Posterior Pituitary Lobe on T1-weighted Magnetic Resonance Imaging.

Kitagawa M, Yamanaka Y, Adachi T, Ito J, Fukase K, Ohta I, Katagiri T.

Intern Med. 2017 Dec 1;56(23):3205-3209. doi: 10.2169/internalmedicine.8616-16. Epub 2017 Oct 11.

42.

Diabetic Hemichorea-hemiballism after Prompt Improvement in Hyperglycemia.

Kitagawa M, Yamanaka Y, Adachi T, Ito J, Fukase K, Ohta I, Katagiri T.

Intern Med. 2017 Nov 15;56(22):3073-3076. doi: 10.2169/internalmedicine.8615-16. Epub 2017 Sep 25.

43.

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.

Nishimukai A, Inoue N, Kira A, Takeda M, Morimoto K, Araki K, Kitajima K, Watanabe T, Hirota S, Katagiri T, Nakamori S, Akazawa K, Miyoshi Y.

PLoS One. 2017 Sep 8;12(9):e0184508. doi: 10.1371/journal.pone.0184508. eCollection 2017.

44.

Successful 5-azacytidine treatment of myeloid sarcoma and leukemia cutis associated with myelodysplastic syndrome: A case report and literature review.

Katagiri T, Ushiki T, Masuko M, Tanaka T, Miyakoshi S, Fuse K, Shibasaki Y, Takizawa J, Aoki S, Sone H.

Medicine (Baltimore). 2017 Sep;96(36):e7975. doi: 10.1097/MD.0000000000007975. Review.

45.

The Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.

Shibasaki Y, Suwabe T, Katagiri T, Tanaka T, Kobayashi H, Fuse K, Ushiki T, Sato N, Yano T, Kuroha T, Hashimoto S, Narita M, Furukawa T, Sone H, Masuko M.

Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13103. Epub 2017 Oct 22.

PMID:
28871665
46.

Immune-Mediated Hematopoietic Failure after Allogeneic Hematopoietic Stem Cell Transplantation: A Common Cause of Late Graft Failure in Patients with Complete Donor Chimerism.

Maruyama K, Aotsuka N, Kumano Y, Sato N, Kawashima N, Onda Y, Maruyama H, Katagiri T, Zaimoku Y, Nakagawa N, Hosomichi K, Ogawa S, Nakao S.

Biol Blood Marrow Transplant. 2018 Jan;24(1):43-49. doi: 10.1016/j.bbmt.2017.08.018. Epub 2017 Aug 30.

47.

Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva.

Katagiri T, Tsukamoto S, Kuratani M.

Bone. 2018 Apr;109:241-250. doi: 10.1016/j.bone.2017.07.024. Epub 2017 Jul 25. Review.

48.

Relationship between Contrast Enhancement of the Perivascular Space in the Basal Ganglia and Endolymphatic Volume Ratio.

Ohashi T, Naganawa S, Katagiri T, Kuno K.

Magn Reson Med Sci. 2018 Jan 10;17(1):67-72. doi: 10.2463/mrms.mp.2017-0001. Epub 2017 Jun 8.

49.

A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.

Yoshimaru T, Ono M, Bando Y, Chen YA, Mizuguchi K, Shima H, Komatsu M, Imoto I, Izumi K, Honda J, Miyoshi Y, Sasa M, Katagiri T.

Nat Commun. 2017 May 30;8:15427. doi: 10.1038/ncomms15427.

50.

The prediction models for postoperative overall survival and disease-free survival in patients with breast cancer.

Shigemizu D, Iwase T, Yoshimoto M, Suzuki Y, Miya F, Boroevich KA, Katagiri T, Zembutsu H, Tsunoda T.

Cancer Med. 2017 Jul;6(7):1627-1638. doi: 10.1002/cam4.1092. Epub 2017 May 24.

Supplemental Content

Loading ...
Support Center